These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
647 related items for PubMed ID: 15534123
41. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision. Shimura M, Yasuda K, Shiono T. Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970 [Abstract] [Full Text] [Related]
42. Pharmacological approach to diabetic retinopathy. De La Cruz JP, González-Correa JA, Guerrero A, de la Cuesta FS. Diabetes Metab Res Rev; 2004 Mar; 20(2):91-113. PubMed ID: 15037985 [Abstract] [Full Text] [Related]
47. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C, Genuth S, Goff DC, Leiter LA, Ismail-Beigi F, Ambrosius WT, Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group. Ophthalmology; 2014 Dec; 121(12):2443-51. PubMed ID: 25172198 [Abstract] [Full Text] [Related]
49. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR, UK Prospective Diabetes Study (IKPDS) Group. Diabet Med; 2001 Mar; 18(3):178-84. PubMed ID: 11318837 [Abstract] [Full Text] [Related]
50. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Beulens JW, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA, Grobbee DE, Stolk RP, AdRem project team, ADVANCE management committee. Diabetologia; 2009 Oct; 52(10):2027-36. PubMed ID: 19633827 [Abstract] [Full Text] [Related]
51. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR. Diabetologia; 2001 Feb; 44(2):156-63. PubMed ID: 11270671 [Abstract] [Full Text] [Related]